Acetaminophen and Intracranial tumor haemorrhage - a phase IV clinical study of FDA data

Summary:

We study 149,321 people who have side effects when taking Acetaminophen. Intracranial tumor haemorrhage is found, especially among people who are female, 30-39 old, also take Emla and have Metastatic malignant melanoma.

The phase IV clinical study analyzes which people take Acetaminophen and have Intracranial tumor haemorrhage. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 21, 2023

149,321 people reported to have side effects when taking Acetaminophen.
Among them, 3 people (0.0%) have Intracranial tumor haemorrhage.

What is Acetaminophen?

Acetaminophen has active ingredients of acetaminophen. It is used in pain. Currently, eHealthMe is studying from 151,280 Acetaminophen users.

What is Intracranial tumor haemorrhage?

Intracranial tumor haemorrhage is found to be associated with 247 drugs and 125 conditions by eHealthMe. Currently, we are studying 445 people who have Intracranial tumor haemorrhage.

Number of Acetaminophen and Intracranial tumor haemorrhage reports submitted per year:

Could Acetaminophen cause Intracranial tumor haemorrhage?

Gender of people who have Intracranial tumor haemorrhage when taking Acetaminophen *:

female: 66.67 %
male: 33.33 %

Age of people who have Intracranial tumor haemorrhage when taking Acetaminophen *:

Common drugs people take besides Acetaminophen *:

Common conditions people have *:

Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 2 people, 66.67%
Tumor: 1 person, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Acetaminophen and have Intracranial tumor haemorrhage?

Check whether Intracranial tumor haemorrhage is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen (the active ingredients of Acetaminophen) and Acetaminophen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.